Kymera Therapeutics, Inc.
KYMR
Classificação em ações
#2251
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Preço da ação
$108.61
Valor de mercado
$8.93B
Variação (1 dia)
3.65%
Variação (1 ano)
81.52%
País
US
Negociar Kymera Therapeutics, Inc. (KYMR)
Categoria
Healthcare
EPS de Kymera Therapeutics, Inc. (KYMR)
EPS em June 2026 TTM: $-3.25
De acordo com os últimos relatórios financeiros e o preço das ações da Kymera Therapeutics, Inc., o EPS atual da empresa (TTM) é $-3.25. No final de 2023, a empresa teve um EPS de $-2.52, uma diminuição em relação a ao EPS de 2022, que foi de $-2.87.
Histórico de EPS da Kymera Therapeutics, Inc. de 2018 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $-3.25 | 9.06% |
| 2024 | $-2.98 | 18.25% |
| 2023 | $-2.52 | -12.20% |
| 2022 | $-2.87 | 37.32% |
| 2021 | $-2.09 | 111.11% |
| 2020 | $-0.99 | 6.45% |
| 2019 | $-0.93 | 93.75% |
| 2018 | $-0.48 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $17.32 | -632.92% |
US
|
|
| $-7.98 | 145.54% |
US
|
|
| $-5.29 | 62.77% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -953.54% |
NL
|
